Largest Taiwanese (TAIEX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Dec 24, 2025

Discover large cap Taiwanese Pharmaceuticals & Biotech companies that are on the TAIEX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

138 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6919
Caliway Biopharmaceuticals
NT$157.502.3%153.6%NT$244.3bNT$240.00PS6981xE124.6%n/a
6446
PharmaEssentia
NT$490.00-2.4%-10.3%NT$181.2bNT$641.66PE37.7xE51.5%0.2%
1795
Lotus Pharmaceutical
NT$278.50-1.8%5.5%NT$73.2bNT$395.20PE15.5xE30.5%2.1%
6472
Bora Pharmaceuticals
NT$492.500.2%-20.0%NT$61.2bNT$788.87PE14.4xE20.3%2.4%
6696
Lin BioScience
NT$400.00-0.2%195.2%NT$33.1bn/aPB11.7xn/an/a
6535
Lumosa Therapeutics
NT$184.50-0.8%-5.9%NT$31.1bNT$250.00PS729.8xS-9.4%n/a
4743
Oneness Biotech
NT$58.001.4%-34.1%NT$27.7bNT$308.00PS236.5xn/a0%
4123
Center Laboratories
NT$37.05-1.3%-8.3%NT$27.7bn/aPE15.6xn/a1.9%
6550
Polaris Group
NT$30.20-6.1%-32.7%NT$23.3bn/aPS328.5xn/an/a
4728
Sunmax Biotechnology
NT$390.00-0.5%42.1%NT$21.2bn/aPE29.6xn/a3.0%
6949
Pell Bio-Med Technology
NT$359.00-5.8%332.5%NT$21.0bn/aPS701.1xn/an/a
4105
TTY Biopharm
NT$83.201.0%13.8%NT$20.7bNT$88.00PE11.6xn/a5.0%
6785
Alar Pharmaceuticals
NT$303.5010.4%110.8%NT$20.3bn/aPS16180.2xn/a0.08%
6589
EirGenix
NT$62.60-0.8%-12.0%NT$18.9bNT$138.00PS20.2xn/an/a
4147
TaiMed Biologics
NT$61.90-3.0%-26.2%NT$16.9bNT$161.00PS27.9xn/an/a
4114
Synmosa Biopharma
NT$31.901.4%4.1%NT$16.0bNT$37.00PE20.8xn/a1.7%
6945
AP Biosciences
NT$183.0013.0%270.4%NT$15.6bn/aPB11.6xn/an/a
6541
Tanvex BioPharma
NT$57.90-3.5%-5.7%NT$15.3bn/aPS68.2xn/an/a
3705
YungShin Global Holding
NT$57.001.2%5.9%NT$15.2bn/aPE15.8xn/a5.3%
6712
Ever Supreme Bio Technology
NT$165.500.9%4.3%NT$14.5bNT$210.00PE27.8xE6.3%2.8%
6620
Handa Pharmaceuticals
NT$87.00-8.4%16.6%NT$13.7bNT$200.00PE20xn/a1.7%
1789
ScinoPharm Taiwan
NT$17.20-1.4%-23.0%NT$13.6bNT$18.00PE70.5xE37.8%2.0%
7878
Pharmasaga
NT$241.505.0%n/aNT$12.9bn/an/an/an/a
6576
Foresee Pharmaceuticals
NT$78.80-1.3%3.4%NT$12.4bNT$126.50PS23.9xn/an/a
Page 1 of 6